The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 14, 2019
Filed:
Dec. 16, 2016
Applicant:
Drexel University, Philadelphia, PA (US);
Inventors:
Sandhya Kortagere, Newtown, PA (US);
Ole Mortensen, Narberth, PA (US);
Andreia C. K. Mortensen, Narberth, PA (US);
Joseph M. Salvino, Chester Springs, PA (US);
Assignee:
Drexel University, Philadelphia, PA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); A61K 31/4439 (2006.01); A61K 31/53 (2006.01); A61K 31/341 (2006.01); A61K 31/381 (2006.01); A61K 31/4184 (2006.01); A61K 31/4196 (2006.01); A61K 31/42 (2006.01); A61K 31/425 (2006.01); A61K 31/4406 (2006.01); A61K 31/47 (2006.01); A61K 31/5365 (2006.01); A61K 45/06 (2006.01); A61K 31/427 (2006.01); A61K 31/4709 (2006.01); C07D 261/14 (2006.01); C07D 275/03 (2006.01); C07D 401/04 (2006.01); C07D 413/14 (2006.01); C07D 417/12 (2006.01); A61K 31/635 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 31/341 (2013.01); A61K 31/381 (2013.01); A61K 31/4184 (2013.01); A61K 31/4196 (2013.01); A61K 31/42 (2013.01); A61K 31/425 (2013.01); A61K 31/427 (2013.01); A61K 31/4406 (2013.01); A61K 31/4439 (2013.01); A61K 31/47 (2013.01); A61K 31/4709 (2013.01); A61K 31/53 (2013.01); A61K 31/5365 (2013.01); A61K 31/635 (2013.01); A61K 45/06 (2013.01); C07D 261/14 (2013.01); C07D 275/03 (2013.01); C07D 401/04 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01);
Abstract
The present invention provides compounds useful for treating or preventing a brain-related disease or disorder. The present invention further provides a method of treating or preventing a brain-related disease or disorder in a patient, comprising administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of modulating the activity of a monoamine transporter.